J9999 Insurance Policy Changes

HCPCS J9999 is officially defined as "Not otherwise classified, antineoplastic drugs." HCPCS J9999 is referenced in 50 tracked payer policy changes from Capital Blue Cross, Blue Cross Blue Shield of North Dakota, and 11 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9999 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.